Tandem Diabetes Care (TNDM) shares fell Monday after analysts from Wells Fargo and Bernstein downgraded the stock.
Tandem shares were more down more than 4% in recent trading after falling as much as 5.8% earlier.
Wells Fargo downgraded the stock to equal weight from overweight and cut its price target to $22 from $38, and Bernstein to market perform from outperform.
Trading volume stood at over 1.8 million shares against a daily average of about 1.3 million.
Price: 21.12, Change: -1.02, Percent Change: -4.61
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.